Bellevue Asset Management, LLC Aytu Biopharma, Inc Transaction History

Bellevue Asset Management, LLC

  • $194 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$2.78 - $5.12 $722 - $1,331
-260 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$5.98 - $13.5 $1,554 - $3,510
260 New
260 $2,000

Others Institutions Holding AYTU

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AYTU BIOPHARMA, INC

AYTU Quotes by TradingView
  • Ticker AYTU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 62,432,700
  • Market Cap $102M
  • Description
  • Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...
More about AYTU
Track This Portfolio

Track Bellevue Asset Management, LLC Portfolio

Follow Bellevue Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email